#United States #Durham #Orlando Health #410 Medical #LifeFlow

410 Medical Raises $12 Million in Growth Financing

In a significant move to propel its commercial operations, 410 Medical, Inc., a North Carolina-based medical device company focused on emergency and critical care technologies, has successfully completed a $12 million financing round. This funding round was led by Orlando Health Ventures, with several notable participants, including Hatteras Venture Partners, Ballad Health, OSF Healthcare, Rex Health Ventures, CU Healthcare Innovations Fund, Sarnova, and Catalyst by Wellstar. The influx of capital will be used to scale operations and support the upcoming launch of the next-generation LifeFlow infuser.

Key Insights from the Financing Round

According to Kyle Chenet, CEO of 410 Medical, the overwhelming interest in this financing round showcases the confidence of investors and healthcare providers in the company’s mission and product offerings. “With this funding, we’re able to expand our commercial reach, bringing LifeFlow to more clinicians and investing in the next generation of our technology,” Chenet stated. This underscores a strong belief in the potential of 410 Medical’s innovations within the healthcare sector, particularly in emergency medical services (EMS) and hospital settings.

410 Medical’s LifeFlow products have already been adopted by over 500 hospitals and EMS agencies nationwide. They serve a critical role in facilitating quick and efficient fluid and blood administration for patients suffering from severe conditions such as sepsis and hemorrhagic shock. Reports indicate that nearly 80,000 patients have benefited from the LifeFlow technology, which highlights its vital role in life-saving scenarios.

The Future of Emergency Care Technologies

The proceeds from this financing will not only be funneled into expanding the company’s existing commercial capabilities but will also invest in the development of next-generation LifeFlow technologies. The anticipated launch of this advanced device, set for 2027, aims to incorporate valuable feedback collected over nearly a decade of collaboration with frontline healthcare providers. Speed, portability, and user-friendliness are essential attributes for these tools, especially in life-or-death situations. The new LifeFlow technology strives to address these critical requirements and other unmet technological needs.

Bobby Helmedag, Managing Director of Orlando Health Ventures, expressed enthusiasm for the partnership, stating, “Orlando Health Ventures is proud to lead this round and deepen our partnership with 410 Medical. LifeFlow addresses a critical gap in resuscitative care, and we’ve seen firsthand the impact it can have for clinicians and patients.” This level of endorsement further reinforces the importance of 410 Medical’s efforts in advancing emergency medical technology.

About 410 Medical, Inc.

Founded in 2013, 410 Medical has positioned itself as a pioneer in developing advanced resuscitation technologies aimed explicitly at improving outcomes for critically ill patients. Their flagship product, LifeFlow, received FDA clearance in 2016 and continues to play a crucial role in enhancing the administration of life-saving fluids and blood products. With an unwavering commitment to innovation, 410 Medical provides crucial support and educational resources for emergency and critical care providers.

For more information about 410 Medical and their innovative medical devices, visit their official website at www.410medical.com. 410 Medical’s focus remains clear: delivering effective resuscitation solutions when every second counts.